Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 7Unknown 5Terminated 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 2Liver Neoplasms 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Chemoembolization, Therapeutic × Clear all
NCT03960008 2024-08-28

SBRTvsTACE

Lahey Clinic

Phase 3 Terminated
9 enrolled 7 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT02524119 2021-02-01

LEE001

University of Texas Southwestern Medical Center

Phase 2 Terminated
5 enrolled 9 charts
Gastrointestinal

Carcinoma, Hepatocellular

NCT02470533 2021-01-27

TRENDY

Erasmus Medical Center

Phase 2 Terminated
100 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡